ANTICORPS MONOCLONAUX, COMPOSITIONS ET METHODES DE DETECTION DE LA PROTEINE DE TYPE MUCINE (MLP) EN TANT QUE BIOMARQUEUR DU CANCER DE L'OVAIRE ET DU PANCREAS
In various embodiments the invention provides anti-mucin-like protein (MLP) monoclonal antibodies, compositions and methods for detecting MLP as a biomarker for mucin-secreting type of cancer such as ovarian or pancreatic cancer.